Name | Number of supported studies | Average coverage | |
---|---|---|---|
goblet cell | 7 studies | 32% ± 6% | |
epithelial cell | 6 studies | 40% ± 11% | |
enterocyte | 5 studies | 30% ± 9% | |
intestinal crypt stem cell | 5 studies | 30% ± 9% | |
transit amplifying cell | 5 studies | 24% ± 8% | |
progenitor cell | 4 studies | 43% ± 15% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
intestine | 3 studies | 25% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 76% | 4419.66 | 738 / 966 | 86% | 182.14 | 452 / 527 |
pancreas | 100% | 283.92 | 328 / 328 | 25% | 6.01 | 45 / 178 |
stomach | 4% | 1.67 | 13 / 359 | 76% | 140.57 | 218 / 286 |
prostate | 42% | 34.76 | 102 / 245 | 3% | 0.53 | 17 / 502 |
esophagus | 1% | 1.27 | 9 / 1445 | 37% | 17.21 | 68 / 183 |
bladder | 5% | 2.95 | 1 / 21 | 29% | 55.55 | 145 / 504 |
lung | 0% | 0.34 | 1 / 578 | 11% | 5.24 | 127 / 1155 |
uterus | 2% | 0.92 | 3 / 170 | 3% | 3.19 | 16 / 459 |
ovary | 2% | 0.48 | 3 / 180 | 0% | 0.08 | 2 / 430 |
breast | 2% | 19.68 | 9 / 459 | 0% | 0 | 0 / 1118 |
adrenal gland | 1% | 0.24 | 2 / 258 | 1% | 0.27 | 2 / 230 |
brain | 1% | 0.46 | 37 / 2642 | 0% | 0.07 | 1 / 705 |
adipose | 1% | 0.43 | 8 / 1204 | 0% | 0 | 0 / 0 |
thymus | 0% | 0.05 | 1 / 653 | 0% | 0.81 | 3 / 605 |
peripheral blood | 1% | 0.28 | 5 / 929 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 0% | 0.15 | 2 / 406 |
spleen | 0% | 0.18 | 1 / 241 | 0% | 0 | 0 / 0 |
skin | 0% | 0.16 | 6 / 1809 | 0% | 0 | 0 / 472 |
heart | 0% | 0.07 | 2 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0.17 | 3 / 1335 | 0% | 0 | 0 / 0 |
muscle | 0% | 0.03 | 1 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
kidney | 0% | 0 | 0 / 89 | 0% | 0 | 0 / 901 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0009790 | Biological process | embryo development |
GO_0009948 | Biological process | anterior/posterior axis specification |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0009887 | Biological process | animal organ morphogenesis |
GO_0001829 | Biological process | trophectodermal cell differentiation |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0045597 | Biological process | positive regulation of cell differentiation |
GO_0060711 | Biological process | labyrinthine layer development |
GO_0030154 | Biological process | cell differentiation |
GO_0008333 | Biological process | endosome to lysosome transport |
GO_0001568 | Biological process | blood vessel development |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0048863 | Biological process | stem cell differentiation |
GO_0060575 | Biological process | intestinal epithelial cell differentiation |
GO_0014807 | Biological process | regulation of somitogenesis |
GO_0045197 | Biological process | establishment or maintenance of epithelial cell apical/basal polarity |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0035019 | Biological process | somatic stem cell population maintenance |
GO_0005654 | Cellular component | nucleoplasm |
GO_0017053 | Cellular component | transcription repressor complex |
GO_0000794 | Cellular component | condensed nuclear chromosome |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0008327 | Molecular function | methyl-CpG binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | CDX2 |
Protein name | Homeobox protein CDX-2 (CDX-3) (Caudal-type homeobox protein 2) CDX2/AS Homeobox protein miniCDX2 variant |
Synonyms | CDX3 |
Description | FUNCTION: Transcription factor which regulates the transcription of multiple genes expressed in the intestinal epithelium (By similarity). Binds to the promoter of the intestinal sucrase-isomaltase SI and activates SI transcription (By similarity). Binds to the DNA sequence 5'-ATAAAAACTTAT-3' in the promoter region of VDR and activates VDR transcription (By similarity). Binds to and activates transcription of LPH (By similarity). Activates transcription of CLDN2 and intestinal mucin MUC2 (By similarity). Binds to the 5'-AATTTTTTACAACACCT-3' DNA sequence in the promoter region of CA1 and activates CA1 transcription (By similarity). Important in broad range of functions from early differentiation to maintenance of the intestinal epithelial lining of both the small and large intestine. Binds preferentially to methylated DNA . . |
Accessions | Q99626 ENST00000381020.8 A0A0M3L9V7 A0A076MKN9 |